Search

Your search keyword '"Xia, Wenjia"' showing total 127 results

Search Constraints

Start Over You searched for: Author "Xia, Wenjia" Remove constraint Author: "Xia, Wenjia"
127 results on '"Xia, Wenjia"'

Search Results

3. Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer

11. Immunotherapy for bilateral multiple ground glass opacities: An exploratory study for synchronous multiple primary lung cancer

14. Additional file 9 of Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer

15. Additional file 4 of Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer

16. Additional file 6 of Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer

17. Additional file 5 of Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer

18. Additional file 8 of Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer

19. Additional file 7 of Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer

20. Additional file 12 of Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer

25. LncRNA FAM83H-AS1 Amplification is Associated With a Poor Prognosis in Lung Adenocarcinoma and Can Serve as A Therapeutic Target

29. Four transcription profile–based models identify novel prognostic signatures in oesophageal cancer.

30. The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma

32. Profiling expression of coding genes, long noncoding RNA , and circular RNA in lung adenocarcinoma by ribosomal RNA ‐depleted RNA sequencing

46. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.

Catalog

Books, media, physical & digital resources